Morfini et al. showed that the half-life of a plasma- derived FVIII concentrate is strongly reduced in 11 vWD patients (mean 2.8 h) in comparison to hemophilia A patients (mean 10.5 h), who have normal levels of VWF [10]. This evidence concerns the gene F8 and von Willebrand disease (hereditary or acquired).